FDA
Pharma

UPDATE: Replimune secures FDA approval after long regulatory battle

The accelerated approval does not mean Replimune’s fate has completely reversed, as the company is still required to provide confirmatory data.
Angus Liu Aug 6, 2026 4:41pm
Why the Real Risk in Hub Transition is Inertia

What Hub Transitions Really Cost Manufacturers

Brought to you by Gifthealth
Zepbound tirzepatide

Eli Lilly's Zepbound preferred by physicians: Spherix survey

Aug 7, 2026 11:36am
showdown clash versus vs crash lightning fight dispute

The Oral GLP-1 Tracker: Lilly's Foundayo builds scripts

Aug 7, 2026 10:45am
Magnifying glass with pills on blue

Regulatory tracker: TransThera scores key cancer nod in China

Aug 7, 2026 10:45am
Novo Nordisk

Novo Nordisk makes Omnicom agency of record for US media buying

Aug 7, 2026 9:44am
More News

Fresenius Kabi recalls morphine lot that could lead to death

Aug 7, 2026 9:30am
Fierce Biotech

Novo Nordisk’s CFO reflects on ‘pressure’ to drive growth

Aug 7, 2026 9:08am

Takeda, Daiichi, Astellas and more—Fierce Pharma Asia

Aug 7, 2026 8:35am

VerilyMe, Bausch + Lomb partner up on dry eye education

Aug 6, 2026 9:35pm